| PUK NYSE ADR price | $30.26 close on July 31, 2026 | StockAnalysis.com real-time quote | August 2, 2026 |
| Market capitalization | $37.38 billion, re-verified as $30.26 x about 1.235 billion ADR-equivalent shares with 0.02% deviation | StockAnalysis.com quote and financial_rigor.py ADR-adjusted market-cap check | August 2, 2026 |
| ADR-adjusted shares | About 1.235 billion ADR equivalents implied by the reported market cap, against 2.53 billion ordinary shares outstanding | StockAnalysis.com statistics, approximately two ordinary shares per ADR | August 2, 2026 |
| FY2025 new business profit | $2,782 million, up 12% at constant exchange rates | Prudential FY2025 results, Form 6-K filed March 18, 2026 | August 2, 2026 |
| FY2025 operating free surplus | $3,059 million, up 15% at constant exchange rates, with a free surplus ratio of 221% | Prudential FY2025 results, Form 6-K filed March 18, 2026 | August 2, 2026 |
| FY2025 IFRS profit after tax | $4,119 million, up 69% at constant exchange rates, with basic EPS of 154.2 cents | Prudential FY2025 results, Form 6-K filed March 18, 2026 | August 2, 2026 |
| FY2025 adjusted operating profit before tax | $3,306 million, up 5% at constant exchange rates | Prudential FY2025 results, Form 6-K filed March 18, 2026 | August 2, 2026 |
| FY2025 APE sales and PVNBP | APE sales of $6,661 million up 6% and PVNBP of $31,925 million up 9% at constant exchange rates | Prudential FY2025 results, Form 6-K filed March 18, 2026 | August 2, 2026 |
| Group TEV equity | $37.8 billion at December 31, 2025, or $14.83 per share, up 15% on an actual exchange rate basis | Prudential FY2025 results, Form 6-K filed March 18, 2026 | August 2, 2026 |
| IFRS shareholders equity | $20.1 billion at December 31, 2025, or $7.90 per share, up 20% on an actual exchange rate basis | Prudential FY2025 results, Form 6-K filed March 18, 2026 | August 2, 2026 |
| 2025 dividend and shareholder returns | 2025 total dividend of 26.60 cents per share up 15%, with more than $7 billion of expected shareholder returns over 2024 to 2027 | Prudential FY2025 results, Form 6-K filed March 18, 2026 | August 2, 2026 |
| S&P Global Ratings upgrade | Financial Strength rating upgraded to AA from AA- for Prudential core entities | Prudential FY2025 results, Form 6-K filed March 18, 2026 | August 2, 2026 |
| Q1 2026 new business profit | $686 million, up 10% at constant exchange rates, with APE sales of $1,823 million up 6% and the margin up 2 points to 38% | Prudential Q1 2026 business performance update, Form 6-K filed April 29, 2026 | August 2, 2026 |
| Q1 2026 buyback | About 20 million shares repurchased for $312 million in the first quarter of 2026, within the $1.2 billion 2026 buyback | Prudential Q1 2026 business performance update, Form 6-K filed April 29, 2026 | August 2, 2026 |
| Eastspring funds under management | $268.9 billion at March 31, 2026, versus $277.7 billion at December 31, 2025 | Prudential Q1 2026 business performance update and FY2025 results, SEC EDGAR 6-K filings | August 2, 2026 |
| 2027 financial objectives | New business profit compound annual growth of 15% to 20% from 2022 to 2027, and at least $4.4 billion of operating free surplus generation in 2027 | Prudential Q1 2026 business performance update, Form 6-K filed April 29, 2026 | August 2, 2026 |
| Life weighted premium income | $28.1 billion for FY2025, up 9% at constant exchange rates | Prudential FY2025 results, Form 6-K filed March 18, 2026 | August 2, 2026 |
| Revenue definition source gap | StockAnalysis.com standardized FY2025 revenue was $19.97 billion and its overview page reported trailing twelve-month revenue of $14.43 billion, both using third-party insurance revenue definitions | Different standardized and IFRS insurance-revenue definitions; official Prudential disclosures are used for this page | August 2, 2026 |
| Analyst consensus | Strong Buy with an average price target of $38.66 across 3 analysts, low $34 and high $43.36 | StockAnalysis.com forecast and analyst ratings | August 2, 2026 |
| Recent analyst actions | J.P. Morgan Overweight with Positive Catalyst Watch into H1 2026 results and maintained Buy on July 13, 2026; Morgan Stanley Overweight with a 1,400 GBp target; Deutsche Bank Sell | StockAnalysis.com news feed and forecast ratings | August 2, 2026 |
| Technical indicators | 52-week range $24.61 to $34.03; 20-day average $28.80; 50-day average $28.08; 100-day average $29.04; 200-day average $29.54; 14-day RSI 62.55 | Barchart and StockAnalysis.com technical snapshots | August 2, 2026 |
| Valuation math | 9.82x trailing IFRS EPS per ADR, 1.92x IFRS book value, 1.02x TEV equity per ADR, 1.76% dividend yield | financial_rigor.py valuation check on StockAnalysis.com inputs | August 2, 2026 |
| Share count and buyback evidence | 2.53 billion ordinary shares outstanding, down 4.71% year over year, with buyback yield near 4.71% and shareholder yield near 6.36% | StockAnalysis.com statistics | August 2, 2026 |
| Next earnings date | H1 2026 results expected Wednesday, August 26, 2026 | StockAnalysis.com statistics | August 2, 2026 |